Search Browse Earnings

Cyclerion Therapeutics, Inc.

Nasdaq:CYCN

Pharmaceutical Preparations·CAMBRIDGE, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Cyclerion Therapeutics, Inc. — SlamSEC

Revenue

$4.5M

+0.0% YoY

FY 2020

Adj. EBITDA

-$12.9M

-285.9% margin

FY 2024

Net Income

-$5.3M

-116.8% margin

FY 2024

EPS (Diluted)

-$2.25

FY 2024

Stock Price

$1.41

+1.4%

2026-03-06

52W Range

$1.03 – $3.79

P/E Ratio

-0.6x

Market Cap

$3.8M

Cash

$7.6M

FY 2024

Total Debt

$3.5M

FY 2022

Net Cash

$4.1M

FY 2022

Enterprise Value

-$249,764.64

Debt / EBITDA

0.3x

FY 2020

EV / EBITDA

0.0x

Employees

—